Form 4: Blueprint Medicines Executive Philina Lee Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Philina Lee, Chief Commercial Officer of Blueprint Medicines, sold 3,733 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 5, 2025, Philina Lee, the Chief Commercial Officer of Blueprint Medicines Corp, sold 3,733 shares of common stock.
- The sale was executed at a price of $88.8 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Lee directly owns 41,996 shares of Blueprint Medicines Corp.
- The sale was not a discretionary trade but an automatic 'sell to cover' transaction to satisfy tax obligations.
Sentiment
Score: 7
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's confidence in the company.
Industry Context
Executive stock sales to cover tax obligations are a common practice and generally don't indicate a negative outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock sale transaction. |
| 03/06/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.